U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019778

Expand all

PRINZIDE (HYDROCHLOROTHIAZIDE; LISINOPRIL)
12.5MG;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; LISINOPRIL
Proprietary Name: PRINZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N019778
Product Number: 003
Approval Date: Nov 18, 1993
Applicant Holder Full Name: MERCK RESEARCH LABORATORIES DIV MERCK CO INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
PRINZIDE (HYDROCHLOROTHIAZIDE; LISINOPRIL)
12.5MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; LISINOPRIL
Proprietary Name: PRINZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N019778
Product Number: 001
Approval Date: Feb 16, 1989
Applicant Holder Full Name: MERCK RESEARCH LABORATORIES DIV MERCK CO INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
PRINZIDE (HYDROCHLOROTHIAZIDE; LISINOPRIL)
25MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; LISINOPRIL
Proprietary Name: PRINZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N019778
Product Number: 002
Approval Date: Feb 16, 1989
Applicant Holder Full Name: MERCK RESEARCH LABORATORIES DIV MERCK CO INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top